Hostname: page-component-586b7cd67f-2plfb Total loading time: 0 Render date: 2024-11-29T09:40:49.888Z Has data issue: false hasContentIssue false
  • English
  • Français

Carbapenem-Resistant Klebsiella pneumoniae in Post-Acute-Care Facilities in Israel

Published online by Cambridge University Press:  02 January 2015

Debby Ben-David ,
Samira Masarwa ,
Shiri Navon-Venezia ,
Hagit Mishali ,
Ilan Fridental ,
Bina Rubinovitch ,
Gill Smollan ,
Yehuda Carmeli ,
Mitchell J. Schwaber  and
Israel PACF CRKP (Post-Acute-Care Facility Carbapenem-Resistant Klebsiella pneumoniae) Working Group
Debby Ben-David*
Affiliation:
National Center for Infection Control, Israel Ministry of Health, Tel Aviv, Israel
Samira Masarwa
Affiliation:
National Center for Infection Control, Israel Ministry of Health, Tel Aviv, Israel
Shiri Navon-Venezia
Affiliation:
National Center for Infection Control, Israel Ministry of Health, Tel Aviv, Israel
Hagit Mishali
Affiliation:
National Center for Infection Control, Israel Ministry of Health, Tel Aviv, Israel
Ilan Fridental
Affiliation:
National Center for Infection Control, Israel Ministry of Health, Tel Aviv, Israel
Bina Rubinovitch
Affiliation:
National Center for Infection Control, Israel Ministry of Health, Tel Aviv, Israel
Gill Smollan
Affiliation:
National Center for Infection Control, Israel Ministry of Health, Tel Aviv, Israel
Yehuda Carmeli
Affiliation:
National Center for Infection Control, Israel Ministry of Health, Tel Aviv, Israel
Mitchell J. Schwaber
Affiliation:
National Center for Infection Control, Israel Ministry of Health, Tel Aviv, Israel
Israel PACF CRKP (Post-Acute-Care Facility Carbapenem-Resistant Klebsiella pneumoniae) Working Group
Affiliation:
National Center for Infection Control, Israel Ministry of Health, Tel Aviv, Israel
*
National Center for Infection Control, 6 Weizmann Street, Tel Aviv 64239, Israel ([email protected])
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective.

To assess the prevalence of and risk factors for carbapenem-resistant Klebsiella pneumoniae (CRKP) carriage among patients in post-acute-care facilities (PACFs) in Israel.

Design, Setting, and Patients.

A cross-sectional prevalence survey was conducted in 12 PACFs. Rectal swab samples were obtained from 1,144 patients in 33 wards. Risk factors for CRKP carriage were assessed among the cohort. Next, a nested, matched case-control study was conducted to define individual risk factors for colonization. Finally, the cohort of patients with a history of CRKP carriage was characterized to determine risk factors for continuous carriage.

Results.

The prevalence of rectal carriage of CRKP among 1,004 patients without a history of CRKP carriage was 12.0%. Independent risk factors for CRKP carriage were prolonged length of stay (odds ratio [OR], 1.001; P < .001), sharing a room with a known carrier (OR, 3.09; P = .02), and increased prevalence of known carriers on the ward (OR, 1.02; P = .013). A policy of screening for carriage on admission was protective (OR, 0.41; P = .03). Risk factors identified in the nested case-control study were antibiotic exposure during the prior 3 months (OR, 1.66; P = .03) and colonization with other resistant pathogens (OR, 1.64; P = .03). Among 140 patients with a history of CRKP carriage, 47% were colonized. Independent risk factors for continued CRKP carriage were antibiotic exposure during the prior 3 months (OR, 3.05; P = .04), receipt of amoxicillin-clavulanate (OR, 4.18; P = .007), and screening within 90 days of the first culture growing CRKP (OR, 2.9; P = .012).

Conclusions.

We found a large reservoir of CRKP in PACFs. Infection-control polices and antibiotic exposure were associated with patient colonization.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 32 , Issue 9 , September 2011 , pp. 845 - 853
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2011

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Dennesen, PJ, Bonten, MI, Weinstein, RA. Multiresistant bacteria as a hospital epidemic problem. Ann Med 1998;30:176–185.Google Scholar
2.Lautenbach, E, Marsicano, R, Tolomeo, P, Heard, M, Serrano, S, Stieritz, DD. Epidemiology of antimicrobial resistance among gram-negative organisms recovered from patients in a multistate network of long-term care facilities. Infect Control Hosp Epidemiol 2009;30:790–793.Google Scholar
3.Trick, WE, Weinstein, RA, DeMarais, PL, et al.Colonization of skilled-care facility residents with antimicrobial-resistant pathogens. J Am Geriatr Soc 2001;49:270–276.Google Scholar
4.Wiener, J, Quinn, JP, Bradford, PA, et al.Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JAMA 1999;281:517–523.Google Scholar
5.Muder, RR, Brennen, C, Wagener, MM, et al.Methicillin-resistant staphylococcal colonization and infection in a long-term care facility. Ann Intern Med 1991;114:107–112.Google Scholar
6.Muto, CA, Jernigan, JA, Ostrowsky, BE, et al.SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol 2003;24:362–386.Google Scholar
7.Centers for Disease Control and Prevention. Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities. MMWR Morb Mortal Wkly Rep 2009;58:256–260.Google Scholar
8.Trick, WE, Weinstein, RA, DeMarais, PL, et al.Comparison of routine glove use and contact-isolation precautions to prevent transmission of multidrug-resistant bacteria in a long-term care facility. J Am Geriatr Soc 2004;52:2003–2009.CrossRefGoogle ScholarPubMed
9.Bradford, PA, Bratu, S, Urban, C, et al.Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 beta-lacta-mases in New York City. Clin Infect Dis 2004;39:55–60.CrossRefGoogle Scholar
10.Bratu, S, Brooks, S, Burney, S, et al.Detection and spread of Escherichia colt possessing the plasmid-borne carbapenemase KPC-2 in Brooklyn, New York. Clin Infect Dis 2007;44:972–975.Google Scholar
11.Cuzon, G, Naas, T, Demachy, MC, Nordmann, P. Plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in Klebsiella pneumoniae isolate from Greece. Antimicrob Agents Chemother 2008;52:796–797.Google Scholar
12.Cai, JC, Zhou, HW, Zhang, R, Chen, GX. Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli isolates possessing the plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in intensive care units of a Chinese hospital. Antimicrob Agents Chemother 2008;52:2014–2018.Google Scholar
13.Hidron, AI, Edwards, JR, Patel, J, et al.NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 2008;29:996–1011.Google Scholar
14.Patel, G, Huprikar, S, Factor, SH, Jenkins, SG, Calfee, DP. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol 2008;29:1099–1106.Google Scholar
15.Schwaber, MJ, Klarfeld-Lidji, S, Navon-Venezia, S, Schwartz, D, Leavitt, A, Carmeli, Y. Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother 2008;52:1028–1033.Google Scholar
16.Borer, A, Saidel-Odes, L, Riesenberg, K, et al.Attributable mortality rate for carbapenem-resistant Klebsiella pneumoniae bacteremia. Infect Control Hosp Epidemiol 2009;30:972–976.Google Scholar
17.Schwaber, MJ, Carmeli, Y. Carbapenem-resistant Enterobacteriaceae. a potential threat. JAMA 2008;300:2911–2913.Google Scholar
18.Schwaber, MJ, Carmeli, Y. Don't forget the bacterial threat. Wall Street Journal. 12 August 2009.Google Scholar
19.Leavitt, A, Navon-Venezia, S, Chmelnitsky, I, Schwaber, MJ, Carmeli, Y. Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae strains in an Israeli hospital. Antimicrob Agents Chemother 2007;51:3026–3029.CrossRefGoogle Scholar
20.Samra, Z, Ofir, O, Lishtzinsky, Y, Madar-Shapiro, L, Bishara, J. Outbreak of carbapenem-resistant Klebsiella pneumoniae producing KPC-3 in a tertiary medical centre in Israel. Int J Antimicrob Agents 2007;30:525–529.Google Scholar
21.Hussein, K, Sprecher, H, Mashiach, T, Oren, I, Kassis, I, Finkelstein, R. Carbapenem resistance among Klebsiella pneumoniae isolates: risk factors, molecular characteristics, and susceptibility patterns. Infect Control Hosp Epidemiol 2009;30:666–671.CrossRefGoogle ScholarPubMed
22.Schwaber, MJ, Lev, B, Israeli, A, et al.Containment of a countrywide outbreak of carbapenem-resistant Klebsiella pneumoniae in Israeli hospitals via a nationally implemented intervention. Clin Infect Dis 2011;52:848–855.CrossRefGoogle Scholar
23.Charlson, ME, Pompei, P, Ales, KL, MacKenzie, CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373–383.Google Scholar
24.Goldstone, LA, Goldstone, J. The Norton score: an early warning of pressure sores? J Adv Nurs 1982;7:419–426.Google Scholar
25.Samra, Z, Bahar, J, Madar-Shapiro, L, Aziz, N, Israel, S, Bishara, J. Evaluation of CHROMagar KPC for rapid detection of carbapenem-resistant Enterobacteriaceae. J Clin Microbiol 2008;46:310–311.Google Scholar
26.Schechner, V, Straus-Robinson, K, Schwartz, D, et al.Evaluation of PCR-based testing for surveillance of KPC-producing carbapenem-resistant members of the Enterobacteriaceae family. J Clin Microbiol 2009;47:3261–3265.Google Scholar
27.Clancy, M, Graepler, A, Wilson, M, Douglas, I, Johnson, J, Price, CS. Active screening in high-risk units is an effective and cost-avoidant method to reduce the rate of methicillin-resistant Staphylococcus aureus infection in the hospital. Infect Control Hosp Epidemiol 2006;27:1009–1017.Google Scholar
28.Morris-Downes, M, Smyth, EG, Moore, J, et al.Surveillance and endemic vancomycin-resistant enterococci: some success in control is possible. J Hosp Infect 2010;75:228–233.Google Scholar
29.Endimiani, A, Depasquale, JM, Forero, S, et al.Emergence of blaKPC-containing Klebsiella pneumoniae in a long-term acute care hospital: a new challenge to our healthcare system. J Antimicrob Chemother 2009;64:1102–1110.Google Scholar
30.Richards, CL Jr., Darradji, M, Weinberg, A, Ouslander, JG. Antimicrobial use in post-acute care: a retrospective descriptive analysis in seven long-term care facilities in Georgia. J Am Med Dir Assoc 2005;6:109–112.CrossRefGoogle ScholarPubMed
31.Nicolle, LE. Infection control in long-term care facilities. Clin Infect Dis 2000;31:752–756.Google Scholar
32.High, KP, Bradley, SF, Gravenstein, S, et al.Clinical practice guideline for the evaluation of fever and infection in older adult residents of long-term care facilities: 2008 update by the Infectious Diseases Society of America. Clin Infect Dis 2009,48:149–171.Google Scholar
33.Pacio, GA, Visintainer, P, Maguire, G, Wormser, GP, Raffalli, J, Montecalvo, MA. Natural history of colonization with vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus, and resistant gram-negative bacilli among long-term-care facility. Infect Control Hosp Epidemiol 2003;24:238–241.Google Scholar
34.Perez, F, Endimiani, A, Ray, AJ, et al.Carbapenem-resistant Aci-netobacter baumannii and Klebsiella pneumoniae across a hospital system: impact of post-acute care facilities on dissemination. J Antimicrob Chemother 2010;65:1807–1818.Google Scholar
35.Ostrowsky, BE, Trick, WE, Sohn, AH, et al.Control of vancomycin-resistant enterococcus in health care facilities in a region. N Engl J Med 2001;344:1427–1433.Google Scholar